Literature DB >> 11872334

In the rat forced swimming test, NA-system mediated interactions may prevent the 5-HT properties of some subacute antidepressant treatments being expressed.

Jean-Philippe Rénéric1, Manuel Bouvard, Luis Stinus.   

Abstract

In the rat forced swimming test (FST), reuptake inhibitors selective of either serotonin (5-HT) or noradrenaline (NA) decrease immobility duration, and increase, respectively, swimming and climbing behaviour. In this study, an almost total 6-OHDA-induced NA-depletion prevented the behavioural effects of desipramine, but not fluoxetine. Interestingly, the serotonin/noradrenaline-reuptake-inhibitor milnacipran, as well as a (desipramine+fluoxetine) combination, could produce both swimming and climbing behaviour in NA-lesioned rats, but not in non-lesioned. The new antidepressant mirtazapine, which enhances both 5-HT and NA transmissions, supposedly through the antagonizing of alpha(2)-adrenoreceptors, dose-dependently reduced immobility and increased climbing behaviour. Interestingly, a (mirtazapine+fluoxetine) combination treatment resulted in additive anti-immobility effects and in the summation of fluoxetine-induced swimming with mirtazapine-induced climbing. Taken together, these data suggest that the NA system mediates presynaptic inhibiting interactions on the 5-HT system, that may involve alpha(2)-receptors, and that may limit the efficacy of mixed serotonin/noradrenaline reuptake inhibition in subacute antidepressant treatments.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11872334     DOI: 10.1016/s0924-977x(02)00007-x

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  10 in total

1.  Effects of milnacipran in animal models of anxiety and memory.

Authors:  Vânia K M Moojen; Márcio Rodrigo Martins; Adalisa Reinke; Gustavo Feier; Fabiano R Agostinho; Edson M Cechin; João Quevedo
Journal:  Neurochem Res       Date:  2006-05-09       Impact factor: 3.996

2.  Effect of antidepressants on body weight, ethology and tumor growth of human pancreatic carcinoma xenografts in nude mice.

Authors:  Lin Jia; Yuan-Yuan Shang; Yu-Yuan Li
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

3.  Appearance of antidepressant-like effect by sildenafil in rats after central muscarinic receptor blockade: evidence from behavioural and neuro-receptor studies.

Authors:  C B Brink; J D Clapton; B E Eagar; B H Harvey
Journal:  J Neural Transm (Vienna)       Date:  2007-09-07       Impact factor: 3.575

4.  Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors.

Authors:  John F Cryan; Olivia F O'Leary; Sung-Ha Jin; Julie C Friedland; Ming Ouyang; Bradford R Hirsch; Michelle E Page; Ashutosh Dalvi; Steven A Thomas; Irwin Lucki
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-17       Impact factor: 11.205

5.  Reduction in the latency of action of antidepressants by 17 beta-estradiol in the forced swimming test.

Authors:  E Estrada-Camarena; N M Vega Rivera; C Berlanga; A Fernández-Guasti
Journal:  Psychopharmacology (Berl)       Date:  2008-09-16       Impact factor: 4.530

6.  Brain region-specific effects of short-term treatment with duloxetine, venlafaxine, milnacipran and sertraline on monoamine metabolism in rats.

Authors:  Katsumasa Muneoka; Yukihiko Shirayama; Morikuni Takigawa; Seiji Shioda
Journal:  Neurochem Res       Date:  2008-08-27       Impact factor: 3.996

7.  Aqueous Extract of Pomegranate Alone or in Combination with Citalopram Produces Antidepressant-Like Effects in an Animal Model of Menopause: Participation of Estrogen Receptors.

Authors:  Brenda Valdés-Sustaita; Carolina López-Rubalcava; María Eva González-Trujano; Cristina García-Viguera; Erika Estrada-Camarena
Journal:  Int J Mol Sci       Date:  2017-12-19       Impact factor: 5.923

8.  Suvorexant and mirtazapine improve chronic pain-related changes in parameters of sleep and voluntary physical performance in mice with sciatic nerve ligation.

Authors:  Hisakatsu Ito; Hiroshi Tsuneki; Toshiyasu Sasaoka; Naoki Toyooka; Mitsuhiro Matsuo; Mitsuaki Yamazaki
Journal:  PLoS One       Date:  2022-02-25       Impact factor: 3.240

9.  Selegiline Ameliorates Depression-Like Behavior in Mice Lacking the CD157/BST1 Gene, a Risk Factor for Parkinson's Disease.

Authors:  Satoka Kasai; Toru Yoshihara; Olga Lopatina; Katsuhiko Ishihara; Haruhiro Higashida
Journal:  Front Behav Neurosci       Date:  2017-05-03       Impact factor: 3.558

10.  Study of Sex Differences in Duloxetine Efficacy for Depression in Transgenic Mouse Models.

Authors:  Yong Xu; Lei Ma; Wei Jiang; Yuhong Li; Gang Wang; Rena Li
Journal:  Front Cell Neurosci       Date:  2017-10-31       Impact factor: 5.505

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.